Benzodiazepine Use and Mortality Risk: A Nationwide Cohort Study on New Benzodiazepine Users With a 5‐Year Follow‐Up

Hanna Särkilä, Heidi Taipale, Antti Tanskanen, Tero Taiminen, Reijo Sund, Terhi Kurko, Jarmo Hietala, Solja Niemelä · 2026

Read Benzodiazepine Use and Mortality Risk: A Nationwide Cohort Study on New Benzodiazepine Users With a 5‐Year Follow‐Up by Hanna Särkilä, Heidi Taipale, Antti Tanskanen, Tero Taiminen, Reijo Sund, Terhi Kurko, Jarmo Hietala, Solja Niemelä (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13630506.txt.

Description

Hanna Särkilä and seven colleagues followed 48,124 Finns who started benzodiazepines or related sleeping drugs in 2006, tracking deaths over five years against the doses actually dispensed. Published in 2026, the nationwide cohort study models use as it changes over time rather than as a single yes-or-no exposure.

Any use period carried somewhat higher mortality than non-use, but the risk concentrated at higher doses. Medium-to-high dosing raised all-cause mortality clearly, very high dosing raised it far more, and low dosing showed no elevation at all. The steepest risks were for the most preventable deaths: overdoses, suicides, and accidents. The authors stress that danger scales with dose and with juggling several of these drugs at once.

Catalog record

CREATORHanna Särkilä, Heidi Taipale, Antti Tanskanen, Tero Taiminen, Reijo Sund, Terhi Kurko, Jarmo Hietala, Solja Niemelä
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE32559
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13630506

Browse the full library · About the Tower of Babel